Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.

Welters A, Meissner T, Grulich-Henn J, Fröhlich-Reiterer E, Warncke K, Mohnike K, Blankenstein O, Menzel U, Datz N, Bollow E, Holl RW.

Orphanet J Rare Dis. 2018 Dec 22;13(1):230. doi: 10.1186/s13023-018-0970-8.

2.

NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.

Welters A, Klüppel C, Mrugala J, Wörmeyer L, Meissner T, Mayatepek E, Heiss C, Eberhard D, Lammert E.

Diabetes Obes Metab. 2017 Sep;19 Suppl 1:95-106. doi: 10.1111/dom.13017. Review.

PMID:
28880473
3.

Treatment with long-acting lanreotide autogel in early infancy in patients with severe neonatal hyperinsulinism.

Corda H, Kummer S, Welters A, Teig N, Klee D, Mayatepek E, Meissner T.

Orphanet J Rare Dis. 2017 Jun 2;12(1):108. doi: 10.1186/s13023-017-0653-x.

4.

Hypoinsulinaemic, hypoketotic hypoglycaemia due to mosaic genetic activation of PI3-kinase.

Leiter SM, Parker VER, Welters A, Knox R, Rocha N, Clark G, Payne F, Lotta L, Harris J, Guerrero-Fernández J, González-Casado I, García-Miñaur S, Gordo G, Wareham N, Martínez-Glez V, Allison M, O'Rahilly S, Barroso I, Meissner T, Davies S, Hussain K, Temple K, Barreda-Bonis AC, Kummer S, Semple RK.

Eur J Endocrinol. 2017 Aug;177(2):175-186. doi: 10.1530/EJE-17-0132. Epub 2017 May 31.

5.

Need for Better Diabetes Treatment: The Therapeutic Potential of NMDA Receptor Antagonists.

Welters A, Lammert E, Mayatepek E, Meissner T.

Klin Padiatr. 2017 Jan;229(1):14-20. doi: 10.1055/s-0042-117831. Epub 2016 Dec 14. Review.

PMID:
27975343
6.

Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers.

Welters A, Lerch C, Kummer S, Marquard J, Salgin B, Mayatepek E, Meissner T.

Orphanet J Rare Dis. 2015 Nov 25;10:150. doi: 10.1186/s13023-015-0367-x. Review.

7.

Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations.

Lachmann MJ, Salgin B, Kummer S, Welters A, Döing C, Zenker M, Wieland I, Mayatepek E, Meissner T.

J Pediatr Endocrinol Metab. 2016 Mar;29(3):281-7. doi: 10.1515/jpem-2015-0192.

PMID:
26581065
8.

DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death.

Jain D, Weber G, Eberhard D, Mehana AE, Eglinger J, Welters A, Bartosinska B, Jeruschke K, Weiss J, Päth G, Ariga H, Seufert J, Lammert E.

PLoS One. 2015 Sep 30;10(9):e0138535. doi: 10.1371/journal.pone.0138535. eCollection 2015.

9.

Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.

Marquard J, Stirban A, Schliess F, Sievers F, Welters A, Otter S, Fischer A, Wnendt S, Meissner T, Heise T, Lammert E.

Diabetes Obes Metab. 2016 Jan;18(1):100-3. doi: 10.1111/dom.12576. Epub 2015 Oct 26.

10.

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

Marquard J, Otter S, Welters A, Stirban A, Fischer A, Eglinger J, Herebian D, Kletke O, Klemen MS, Stožer A, Wnendt S, Piemonti L, Köhler M, Ferrer J, Thorens B, Schliess F, Rupnik MS, Heise T, Berggren PO, Klöcker N, Meissner T, Mayatepek E, Eberhard D, Kragl M, Lammert E.

Nat Med. 2015 Apr;21(4):363-72. doi: 10.1038/nm.3822. Epub 2015 Mar 16.

PMID:
25774850
11.

Association of exercise-induced hyperinsulinaemic hypoglycaemia with MCT1-expressing insulinoma.

Marquard J, Welters A, Buschmann T, Barthlen W, Vogelgesang S, Klee D, Krausch M, Raffel A, Otter S, Piemonti L, Mayatepek E, Otonkoski T, Lammert E, Meissner T.

Diabetologia. 2013 Jan;56(1):31-5. doi: 10.1007/s00125-012-2750-7. Epub 2012 Oct 17.

PMID:
23073708
12.

[Color vision testing in patients with diabetes mellitus and arterial hypertension].

Lüthke S, Welters A, Kropf S, Böckelmann I.

Ophthalmologe. 2010 Oct;107(10):923-9. doi: 10.1007/s00347-010-2169-9. German.

PMID:
20532521
13.

Thrombomodulin in intensive care patients.

Boldt J, Wollbrück T, Sonneborn S, Welters A, Hempelmann G.

Intensive Care Med. 1995 Aug;21(8):645-50.

PMID:
8522668
14.

Thrombomodulin in pediatric cardiac surgery.

Boldt J, Knothe C, Schindler E, Welters A, Dapper FF, Hempelmann G.

Ann Thorac Surg. 1994 Jun;57(6):1584-9.

PMID:
8010806
15.

Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations.

Boldt J, Zickmann B, Schindler E, Welters A, Dapper F, Hempelmann G.

J Thorac Cardiovasc Surg. 1994 May;107(5):1215-21.

PMID:
7513776

Supplemental Content

Loading ...
Support Center